Board Member

Sharonann Lynch has worked for 25 years in the global health field. She is currently Co-Director of the Center for Global Health Policy and Politics (GHPP) at Georgetown University’s O’Neill Institute for National and Global Health Law.

Alternate Board Member

Over the past two decades, Olayide Akanni has served in various capacities with several other advocacy-based coalitions in promoting Health financing, HIV/AIDS and TB treatment literacy, sexual and reproductive health and rights (SRHR), capacity building for media and a diverse range of civil society groups in research, community engagement, and policy monitoring to support universal access to prevention, treatment, and care services. 

She is the National Coordinator for the Civil Society Network for the Eradication of Tuberculosis in Nigeria (TB) Network. Before working in the non-profit sector, Olayide was a Health Correspondent for Punch Newspapers, a leading National Newspaper in Nigeria. Olayide holds a Bachelor’s and Master’s in Biochemistry from the University of Ibadan, Nigeria and an MBA from the Lagos Business School of the Pan Atlantic University (formerly Pan African University).

Key Advisor & Previous Board member 

Senior Policy Analyst, Health GAP (Global Access Project), Professor Emeritus, Northeastern U. School of Law, Boston, USA

Unitaid Areas of Interest:  HIV/AIDS and co-infections, covid-19 and pandemic prevention, preparedness, and response, mpox, diagnostics, intellectual property, regional manufacturing, equitable access, long-acting formulations, regulatory issues, committees and governance

Having previously served as alternate board member and board member from 2013-2018, I have been a key advisor since 2018.  My goal is for Unitaid to become even more effective in accelerating affordable and equitable access to well-adapted health technologies needed in low- and middle-income countries.

Key Advisor & Previous Board member 

Principal Consultant at Matahari Global Solutions

Key Advisor & Previous Board member 

Consultant in global health policy and programmes and access to medicines

Key Advisor

Executive Director of Chasing Zero 

Key Advisor

Senior Business Consultant/Advisor, Edinburgh UK

Unitaid Areas of Interest: Climate and Health, Regional Manufacturing, Access, Community Engagement, Digital Health and AI, Resource Mobilisation, Primary

Key Advisor

Senior Advisor, Global Policy at AVAC based in Lilongwe, Malawi

Unitaid Areas of Interest: HIV & co-infections, PPPR, AMR, Covid-19 & Pandemic related, Climate Change and Health, Mpox, Regional Manufacturing, Community Engagement, regulatory

I am looking forward to working with the incredible team of community leaders that are shaping conversations around equitable access to health products and technologies

Founder/Director, Mayittah Group, Harare, Zimbabwe

Unitaid Areas of Interest: Cross-Cutting / Strategic Initiatives, Secretariat/Board and Delegation work areas

I am joining the Key Advisor team to contribute my expertise in driving equitable access to healthcare innovations, particularly for underserved communities in the Global South, and to ensure that voices from marginalised groups are represented in UNITAID’s strategic decisions.

Key Advisor

Founder and Director of the Latin American Corporation for Intellectual Property Research for Development, Corporación Innovarte

Key Advisor

Co-Chair of O’Neill Institute – Lancet Commission on Racism and Structural Discrimination and Global Health.

Founding member of the Decolonizing Global Health Alumni group at London School of Hygiene and Tropical Medicine (LSHTM). 

Technical Director of the Global Institute for Disease Elimination.

Senior Scholar at the O’Neill Institute at Georgetown Law University and an Associate Fellow at Chatham House.

Key Advisor

Chief Executive Officer, DOPASI Foundation, Pakistan

Unitaid Areas of Interest: TB, Diagnostics, Digital Health & AI, Climate and Health, RMNCH, PPPR, Community Engagement, Equitable Access, Resource Mobilisation, Governance and Policy.

Kinz ul Eman is a global health leader with over 16 years of experience working across health innovation, health systems and civil society in low- and middle-income countries. She currently serves as CEO of DOPASI Foundation. Her work focuses particularly on accelerating access to innovative diagnostics, treatments and models of care, strengthening community and country engagement, and ensuring that new health technologies translate into equitable and sustainable impact for the people and communities who need them most.

Key Advisor

Over the past two decades, Chetali has worked at the intersection of intellectual property, pharmaceutical regulation, trade policy, and access to medicines. At Third World Network, she engages with Ministries of Health, national regulatory authorities, industry stakeholders, communities, and patient advocacy groups to advance equitable access to affordable health technologies. Her work spans working on patents and trade secrets issues, trade agreement interventions, regulatory frameworks, biologics, and HIV therapeutics including long-acting antiretrovirals, alongside TB vaccines and medicines, NCDs and rare diseases. She also serves on Subject Expert Committees of the Government of India, contributing to national efforts to facilitate access to affordable biotechnology, AI, and deep-tech products.

Prior to joining Third World Network, she gained industry and consulting experience at Ranbaxy Laboratories Ltd. (Daiichi Sankyo Group), Novo Nordisk, and Evalueserve. Her work has included market-access strategy, intellectual-property management, technology licensing and transfer, patent valuation, pharmaceutical product in- and out-licensing, and IP litigation. She holds a law degree and an LLM from the London School of Economics, with an academic background in biotechnology/life sciences and specialised trainings in patent law and regulatory affairs.

NGO Delegation Liaison Officer

molly@stopaids.org.uk